Versago Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $1.65M
Latest Deal Amount
  • Investors
  • 1

Versago General Information

Description

Developer of a true platform technology designed to offer safe and reliable access to vascular technologies. The company's true platform technology develops a patented system that displaces multiple traditional access applications in apheresis and chemotherapy, enabling patients to get advanced treatments without needle sticks or device misses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Surgical Devices
Therapeutic Devices
Primary Office
  • 375 West Street
  • West Bridgewater, MA 02379
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Versago Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 25-Feb-2016 $1.65M 00.000 000.00 Completed Startup
1. Angel (individual) 06-Aug-2015 00000 00000 Completed Startup
To view Versago’s complete valuation and funding history, request access »

Versago Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Versago’s complete cap table history, request access »

Versago Patents

Versago Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3086211-A1 Medical access ports, transfer devices and methods of use thereof Pending 21-Dec-2017 00000000000
EP-3727558-A1 Medical access ports, transfer devices and methods of use thereof Pending 21-Dec-2017 00000000000
US-20190192769-A1 Medical access ports, transfer devices and methods of use thereof Granted 21-Dec-2017 00000000000
US-11058815-B2 Medical access ports, transfer devices and methods of use thereof Active 21-Dec-2017 00000000000 000
AU-2016294584-A1 Medical access ports, transfer devices and methods of use thereof Granted 14-Jul-2015 A61M39/0208

Versago Executive Team (3)

Name Title Board Seat Contact Info
Andrea Patisteas Co-Founder, Chief Executive Officer & Board Member
Ross Garofalo Chief Financial Officer
John Butziger Chief Operating Officer
To view Versago’s complete executive team members history, request access »

Versago Board Members (2)

Name Representing Role Since
Andrea Patisteas Versago Co-Founder, Chief Executive Officer & Board Member 000 0000
Steven Tallarida Versago Board Member 000 0000
To view Versago’s complete board members history, request access »

Versago Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Versago Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Primo Medical Group Corporation Minority 000 0000 000000 0
To view Versago’s complete investors history, request access »